| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Canada (Primary) | PRIMARYCAN | Univ | 1,688 | 3,243,183 | 0.00% | 3.35% | -0.96% | 5.14% | 14.68% | 40.58% |
| Healthcare | HEALTHCARE | Sector | 70 | 9,536 | 0.00% | 3.89% | -2.46% | 3.81% | 12.15% | 34.99% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 19 | 2,210 | 0.00% | 5.05% | 1.65% | -3.38% | 16.31% | 46.46% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 7 | 1,082 | 0.00% | 6.00% | -6.39% | -13.82% | 9.58% | 59.79% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 2 | 223 | 0.00% | -4.18% | -33.51% | -50.76% | -17.89% | 10.02% |
| Musculoskeletal System Biopharmaceuticals | MUSCULOSKELETAL | SubInd | 1 | 443 | 0.00% | 6.87% | -7.87% | -2.64% | 18.45% | 118.20% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 7 | 1,082 | 0.00% | 6.00% | -6.39% | -13.82% | 9.58% | 59.79% |
| S&P/TSX Capped Composite | XIC:CANXIC:CAN | Benchmark | 221 | 3,840,092 | 0.44% | 3.92% | -2.21% | 3.34% | 11.00% | 33.99% |
| Cardiovascular System Biopharmaceuticals | CARDIOVASCULAR | SubInd | 2 | 33 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Endocrinology and Metabolism Biopharmaceuticals | ENDOCRINOLOGY | SubInd | 1 | 37 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 28.45% |
| Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 1 | 345 | 0.00% | 8.55% | 27.63% | 28.50% | 31.93% | 57.85% |
* Colors indicate performance relative to the benchmark.